You searched for "wellbeing"
Eye Capacity: clinical need should drive ophthalmic service provision
1 February 2014
| Rod McNeil
Almost two million people in the UK suffer sight loss, a number forecast to double over coming decades. Major causes of blindness are age-related macular degeneration (AMD), glaucoma, diabetic retinopathy, cataract and uncorrected refractive error. Prevalence of these sight-threatening conditions...
Renewed momentum in ocular gene and cell therapy, broadening application to chronic disease
Gene and cell therapies offer the prospect of ground-breaking new avenues for the treatment of diseases, reflected in a renewed explosion of interest and investment in retinal gene therapy. Rod McNeil reports recent clinical trial readouts across a diverse range...Part 1: The Arclight Project – Frugal tech for sight
3 April 2024
| Andrew Blaikie, Immaculate Atukunda, Obaid Kousha
|
EYE - General
Click here for Part 2 on this topic, and here for Part 3 The Arclight Project is a mix of frugal design, manufacturing, distribution, teaching, research, and advocacy, all wrapped up in a social enterprise based at the University of...
See sweet to C-suite: Carrie MacEwen
2 April 2025
| David Lockington
|
EYE - General
The business world tells us, “Know your why.” But increasingly, we live in a society where people think, “Why bother?” In this interview, David wants to know what makes Carrie MacEwen tick, and why she bothered to get involved locally,...
Results from two eye tests suggest that vision is a battle of the sexes
31 March 2022
The research was developed by Contact Lenses UK to explore the nation's eye health, by analysing participants ‘colour vision’ and ‘perception’.
The gift of family
3 February 2023
| David Lockington
“Your kids look just like you!” is an oft-heard phrase at family gatherings. Setting aside the obvious explanation of basic genetics, similarities and recurrent character traits are well recognised within a family unit. Shared positive mutual experiences shape these attitudes...
Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up
29 March 2023
|
glaucoma
Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.